Kidney cancer patients prefer pazopanib over sunitinibNewer agent comes out tops in blinded crossover trial Selumetinib shows promise in ovarian cancerOral MEK inhibitor produces ‘striking’ results in early clinical trial Hypoxia predicts prostate cancer recurrence Low tumour oxygenation linked with biochemical relapse within 48 months of treatment Metformin slows prostate cancer growth Small Canadian study measures markers of cell proliferation Trials fine-tune treatment of low-risk thyroid cancer Less radioiodine as effective as higher dose, studies show Scan kids with caution Beware circulating cells New study backs flexible sigmoidoscopy as screening tool Major U.S. trial shows reduction in colorectal cancer mortality Statins may slow prostate growth Finding emerges from secondary analysis of dutasteride trial Male pattern baldness linked to prostate cancer But finger-length ratio not a risk factor, Canadian study shows First Previous 41 42 43 44 45 Next Last